The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Very interesting article at this date's www.internalmedicinenews.com on treating mCRC

coloCan
coloCan CSN Member Posts: 1,944 Member
edited February 2011 in Colorectal Cancer #1
Once on home page ,click on second title listed under Top Stories:

Antibody Combination Targets Multiple Pathways in mCRC

(title says it all)



This date too, the Mayo Clinic Living With Cancer newsletter has item titled:

Monoclonal antibody drugs for cancer treatment: How they work

which contains brief description of Avastin,Erbitux and Vectibux, among others

Live and learn
Like Care

Comments

  • thxmiker
    thxmiker CSN Member Posts: 1,278 Member
    #2
    good info!
    Thanks for posting that site.
    (www.InternalMedicineNews.com or www.InternalMedicalNews.com)

    There is a lot of good information there.

    Best Always, mike
    Like Care

Discussion Boards